MRVI

Maravai Lifesciences Holdings Stock Analysis

AI Rating

Fair
  • Quality4/10
  • Growth↓ 4/10
  • Momentum↓ 4/10
Maravai Lifesciences Holdings sales and earnings growth
MRVI Growth
Neutral
  • Revenue Y/Y↓ -30.53%
  • EPS Y/Y↑ 48.78%
  • FCF Y/Y↓ -4478.85%
Maravai Lifesciences Holdings gross and profit margin trends
MRVI Profitability
Low
  • Gross margin ↑ 20.90%
  • EPS margin↓ -63.10%
  • ROIC↓ -16.40%
Maravai Lifesciences Holdings net debt vs free cash flow
MRVI Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↓ 1.2
  • Interest coverage↓ -3.0

Maravai Lifesciences Holdings stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗